174 related articles for article (PubMed ID: 37549179)
1. CYLD stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
Huyen NT; Ngoc NT; Giang NH; Trang DT; Hanh HH; Binh VD; Giang NV; Canh NX; Xuan NT
PLoS One; 2023; 18(8):e0283586. PubMed ID: 37549179
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological significance of cylindromatosis in the vascular endothelium and macrophages for the initiation of age-related atherogenesis.
Imaizumi Y; Takami Y; Yamamoto K; Nagasawa M; Nozato Y; Nozato S; Takeshita H; Wang C; Yokoyama S; Hayashi H; Hongyo K; Akasaka H; Takeya Y; Sugimoto K; Nakagami H; Rakugi H
Biochem Biophys Res Commun; 2019 Jan; 508(4):1168-1174. PubMed ID: 30554661
[TBL] [Abstract][Full Text] [Related]
3. TIGIT blockade repolarizes AML-associated TIGIT
Brauneck F; Fischer B; Witt M; Muschhammer J; Oelrich J; da Costa Avelar PH; Tsoka S; Bullinger L; Seubert E; Smit DJ; Bokemeyer C; Ackermann C; Wellbrock J; Haag F; Fiedler W
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36549780
[TBL] [Abstract][Full Text] [Related]
4. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
Zhang LM; Zhou JJ; Luo CL
Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
[TBL] [Abstract][Full Text] [Related]
5. Research on mechanism of miR-130a in regulating autophagy of bladder cancer cells through CYLD.
Dai H; Liu C; Liu Y; Zhang Z; Peng C; Wang Z; Zheng J; Li C; Yu W; Cheng F
J BUON; 2020; 25(3):1636-1642. PubMed ID: 32862616
[TBL] [Abstract][Full Text] [Related]
6. Taking the STING out of acute myeloid leukemia through macrophage-mediated phagocytosis.
Dalton WB; Ghiaur G; Resar LM
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35229728
[TBL] [Abstract][Full Text] [Related]
7. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.
Manganaro L; Pache L; Herrmann T; Marlett J; Hwang Y; Murry J; Miorin L; Ting AT; König R; García-Sastre A; Bushman FD; Chanda SK; Young JA; Fernandez-Sesma A; Simon V
J Virol; 2014 Jul; 88(13):7528-40. PubMed ID: 24760882
[TBL] [Abstract][Full Text] [Related]
9. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
Wang Y; Zhou Q; Ma JJ
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
[TBL] [Abstract][Full Text] [Related]
10. Associations of A20, CYLD, Cezanne and JAK2 Genes and Immunophenotype with Psoriasis Susceptibility.
Giang NH; Lien NTK; Trang DT; Huong PT; Hoang NH; Xuan NT
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893484
[No Abstract] [Full Text] [Related]
11. LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation.
Moore JA; Mistry JJ; Hellmich C; Horton RH; Wojtowicz EE; Jibril A; Jefferson M; Wileman T; Beraza N; Bowles KM; Rushworth SA
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 34990402
[TBL] [Abstract][Full Text] [Related]
12. Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells.
La T; Jin L; Liu XY; Song ZH; Farrelly M; Feng YC; Yan XG; Zhang YY; Thorne RF; Zhang XD; Teng L
Oncol Res; 2020 Sep; 28(4):385-398. PubMed ID: 32252875
[TBL] [Abstract][Full Text] [Related]
13. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
[TBL] [Abstract][Full Text] [Related]
14. Truncation of the deubiquitinating domain of CYLD in myelomonocytic cells attenuates inflammatory responses.
Tsagaratou A; Kontoyiannis DL; Mosialos G
PLoS One; 2011 Jan; 6(1):e16397. PubMed ID: 21283724
[TBL] [Abstract][Full Text] [Related]
15. Effects of Vinblastine and Vincristine on the function of chronic myeloid leukemic cells through expression of A20 and CYLD.
Hoang NH; Huyen NT; Trang DT; Canh NX; Mao CV; Sopjani M; Vuong NB; Xuan NT
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):47-53. PubMed ID: 37114273
[TBL] [Abstract][Full Text] [Related]
16. Anti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous Leukemia.
Somintara S; Leardkamolkarn V; Suttiarporn P; Mahatheeranont S
PLoS One; 2016; 11(1):e0146869. PubMed ID: 26752299
[TBL] [Abstract][Full Text] [Related]
17. Novel nanocarriers for silencing anti-phagocytosis CD47 marker in acute myeloid leukemia cells.
Hassan EM; Zou S
Colloids Surf B Biointerfaces; 2022 Sep; 217():112609. PubMed ID: 35667200
[TBL] [Abstract][Full Text] [Related]
18. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B
Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382
[TBL] [Abstract][Full Text] [Related]
19. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
20. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
